WYC-209 inhibited GC malignant progression by down-regulating WNT4 through RARα

References

• Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69–12. doi:10.3322/caac.20107.
   PubMed Web of Science ®Google Scholar
• Correa P. Gastric cancer: overview. Gastroenterol Clin North Am. 2013;42(2):211–7. doi:10.1016/j.gtc.2013.01.002.
   PubMed Web of Science ®Google Scholar
• Sitarz R, Skierucha M, Mielko J, Offerhaus GJA, Maciejewski R, Polkowski WP. Gastric cancer: epidemiology, prevention, classification, and treatment. Cancer Manag Res. 2018;10:239–248. doi:10.2147/CMAR.S149619.
   PubMed Web of Science ®Google Scholar
• Oh DY, Bang YJ. Adjuvant and neoadjuvant therapy for gastric cancer. Curr Treat Options Oncol. 2013;14(3):311–20. doi:10.1007/s11864-013-0238-4.
   PubMed Web of Science ®Google Scholar
• Sun SY, Lotan R. Retinoids and their receptors in cancer development and chemoprevention. Crit Rev Oncol Hematol. 2002;41(1):41–55. doi:10.1016/s1040-8428(01)00144-5.
   PubMed Web of Science ®Google Scholar
• Freemantle SJ, Dragnev KH, Dmitrovsky E. The retinoic acid paradox in cancer chemoprevention. J Natl Cancer Inst. 2006;98(7):426–7. doi:10.1093/jnci/djj116.
   PubMedGoogle Scholar
• Altucci L, Rossin A, Hirsch O, Nebbioso A, Vitoux D, Wilhelm E, Guidez F, De Simone M, Schiavone EM, Grimwade D, et al. Rexinoid-triggered differentiation and tumor-selective apoptosis of acute myeloid leukemia by protein kinase A-mediated desubordination of retinoid X receptor. Cancer Res. 2005;65(19):8754–8765. doi:10.1158/0008-5472.CAN-04-3569.
   PubMed Web of Science ®Google Scholar
• Dragnev KH, Petty WJ, Shah SJ, Lewis LD, Black CC, Memoli V, Nugent WC, Hermann T, Negro-Vilar A, Rigas JR, et al. A proof-of-principle clinical trial of bexarotene in patients with non-small cell lung cancer. Clin Cancer Res. 2007;13(6):1794–1800. doi:10.1158/1078-0432.CCR-06-1836.
   PubMed Web of Science ®Google Scholar
• Kastner P, Mark M, Ghyselinck N, Krezel W, Dupé V, Grondona JM, Chambon P. Genetic evidence that the retinoid signal is transduced by heterodimeric RXR/RAR functional units during mouse development. Development. 1997;124(2):313–26. doi:10.1242/dev.124.2.313.
   PubMed Web of Science ®Google Scholar
• Prakash R. The acute and chronic toxic effects of vitamin a. Am J Clin Nutr. 2006;84(2):462. author reply 462-3. doi:10.1093/ajcn/84.2.462.
   PubMed Web of Science ®Google Scholar
• Nau H. Embryotoxicity and teratogenicity of topical retinoic acid. Skin Pharmacol Physiol. 1993;6(Suppl 1):35–44. doi:10.1159/000211162.
   Google Scholar
• Barnard JH, Collings JC, Whiting A, Przyborski SA, Marder TB. Synthetic retinoids: structure–activity relationships. Chem A Eur J. 2009;15(43):11430–11442. doi:10.1002/chem.200901952.
   PubMed Web of Science ®Google Scholar
• Aouad P, Saikali M, Abdel-Samad R, Fostok S, El-Houjeiri L, Pisano C, Talhouk R, Darwiche N. Antitumor activities of the synthetic retinoid ST1926 in two-dimensional and three-dimensional human breast cancer models. Anticancer Drugs. 2017;28(7):757–770. doi:10.1097/CAD.0000000000000511.
   PubMed Web of Science ®Google Scholar
• Chen J, Cao X, An Q, Zhang Y, Li K, Yao W, Shi F, Pan Y, Jia Q, Zhou W, et al., Inhibition of cancer stem cell like cells by a synthetic retinoid. Nat Commun. 2018;9(1):1406. doi:10.1038/s41467-018-03877-7.
   PubMedGoogle Scholar
• Tan Y, Tajik A, Chen J, Jia Q, Chowdhury F, Wang L, Chen J, Zhang S, Hong Y, Yi H, et al. Matrix softness regulates plasticity of tumour-repopulating cells via H3K9 demethylation and Sox2 expression. Nat Commun. 2014;5:4619. doi:10.1038/ncomms5619.
   PubMed Web of Science ®Google Scholar
• Bushue N, Wan YJ. Retinoid pathway and cancer therapeutics. Adv Drug Deliv Rev. 2010;62(13):1285–98. doi:10.1016/j.addr.2010.07.003.
   PubMed Web of Science ®Google Scholar
• Zou S, Tong Q, Liu B, Huang W, Tian Y, Fu X. Targeting STAT3 in cancer immunotherapy. Mol Cancer. 2020;19(1):145. doi:10.1186/s12943-020-01258-7.
   PubMed Web of Science ®Google Scholar
• Shariati M, Meric-Bernstam F. Targeting AKT for cancer therapy. Expert Opin Investig Drugs. 2019;28(11):977–988. doi:10.1080/13543784.2019.1676726.
   PubMed Web of Science ®Google Scholar
• Zhang L, Zhu Z, Yan H, Wang W, Wu Z, Zhang F, Zhang Q, Shi G, Du J, Cai H, et al. Creatine promotes cancer metastasis through activation of Smad2/3. Cell Metab. 2021;33(6):1111–1123 e4. doi:10.1016/j.cmet.2021.03.009.
   PubMed Web of Science ®Google Scholar
• Yu F, Yu C, Li F, Zuo Y, Wang Y, Yao L, Wu C, Wang C, Ye L. Wnt/β-catenin signaling in cancers and targeted therapies. Sig Transduct Target Ther. 2021;6(1):307. doi:10.1038/s41392-021-00701-5.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Pan Y, Ji J, Xu Y, Zhang Q, Qin L. Roles and action mechanisms of WNT4 in cell differentiation and human diseases: a review. Cell Death Discov. 2021;7(1):287. doi:10.1038/s41420-021-00668-w.
   PubMed Web of Science ®Google Scholar
• Tang XH, Gudas LJ. Retinoids, retinoic acid receptors, and cancer. Annu Rev Pathol Mech Dis. 2011;6(1):345–364. doi:10.1146/annurev-pathol-011110-130303.
   PubMedGoogle Scholar
• Muindi J, Frankel SR, Miller WH Jr., Jakubowski A, Scheinberg DA, Young CW, Dmitrovsky E, Warrell RP Jr. Continuous treatment with all-trans retinoic acid causes a progressive reduction in plasma drug concentrations: implications for relapse and retinoid “resistance” in patients with acute promyelocytic leukemia. Blood. 1992;79(2):299–303. doi:10.1182/blood.V79.2.299.299.
   PubMed Web of Science ®Google Scholar
• Bahmad HF, Samman H, Monzer A, Hadadeh O, Cheaito K, Abdel-Samad R, Hayar B, Pisano C, Msheik H, Liu YN, et al. The synthetic retinoid ST1926 attenuates prostate cancer growth and potentially targets prostate cancer stem-like cells. Mol Carcinog. 2019;58(7):1208–1220. doi:10.1002/mc.23004.
   PubMed Web of Science ®Google Scholar
• Borthwick AD, Goncalves MB, Corcoran JPT. Recent advances in the design of RAR alpha and RAR beta agonists as orally bioavailable drugs. A review. Bioorg Med Chem. 2020;28(20):115664. doi:10.1016/j.bmc.2020.115664.
   PubMed Web of Science ®Google Scholar
• Dragnev KH, Ma T, Cyrus J, Galimberti F, Memoli V, Busch AM, Tsongalis GJ, Seltzer M, Johnstone D, Erkmen CP, et al. Bexarotene plus erlotinib suppress lung carcinogenesis independent of KRAS mutations in two clinical trials and transgenic models. Cancer Prev Res (Phila). 2011;4(6):818–828. doi:10.1158/1940-6207.CAPR-10-0376.
   PubMed Web of Science ®Google Scholar
• Qi F, Qin W, Zhang Y, Luo Y, Niu B, An Q, Yang B, Shi K, Yu Z, Chen J, et al., Sulfarotene, a synthetic retinoid, overcomes stemness and sorafenib resistance of hepatocellular carcinoma via suppressing SOS2-RAS pathway. J Exp Clin Cancer Res. 2021;40(1):280. doi:10.1186/s13046-021-02085-4.
   PubMed Web of Science ®Google Scholar
• Hou P, Li Y, Zhang X, Liu C, Guan J, Li H, Zhao T, Ye J, Yang W, Liu K, et al. Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds. Sci. 2013;341(6146):651–4. doi:10.1126/science.1239278.
   PubMed Web of Science ®Google Scholar
• Vouyovitch CM, Perry JK, Liu DX, Bezin L, Vilain E, Diaz JJ, Lobie PE, Mertani HC. WNT4 mediates the autocrine effects of growth hormone in mammary carcinoma cells. Endocr Relat Cancer. 2016;23(7):571–85. doi:10.1530/ERC-15-0528.
   PubMed Web of Science ®Google Scholar
• Yang D, Li Q, Shang R, Yao L, Wu L, Zhang M, Zhang L, Xu M, Lu Z, Zhou J, et al. WNT4 secreted by tumor tissues promotes tumor progression in colorectal cancer by activation of the Wnt/beta-catenin signalling pathway. J Exp Clin Cancer Res. 2020;39(1):251. doi:10.1186/s13046-020-01774-w.
   PubMed Web of Science ®Google Scholar
• Li X, Li Z, Wang J, Li Z, Cui H, Dai G, Chen S, Zhang M, Zheng Z, Zhan Z, et al. Wnt4 signaling mediates protective effects of melatonin on new bone formation in an inflammatory environment. FASEB J. 2019;33(9):10126–10139. doi:10.1096/fj.201900093RR.
   PubMed Web of Science ®Google Scholar
• Allenby G, Bocquel MT, Saunders M, Kazmer S, Speck J, Rosenberger M, Lovey A, Kastner P, Grippo JF, Chambon P, et al. Retinoic acid receptors and retinoid X receptors: interactions with endogenous retinoic acids. Proc Natl Acad Sci USA. 1993;90(1):30–34. doi:10.1073/pnas.90.1.30.
   PubMed Web of Science ®Google Scholar
• Giguere V, Ong ES, Segui P, Evans RM. Identification of a receptor for the morphogen retinoic acid. Nature. 1987;330(6149):624–9. doi:10.1038/330624a0.
   PubMed Web of Science ®Google Scholar
• Mangelsdorf DJ, Borgmeyer U, Heyman RA, Zhou JY, Ong ES, Oro AE, Kakizuka A, Evans RM. Characterization of three RXR genes that mediate the action of 9-cis retinoic acid. Genes Dev. 1992;6(3):329–44. doi:10.1101/gad.6.3.329.
   PubMed Web of Science ®Google Scholar
• Rogatsky E. Pandora box of BCA assay. Investigation of the accuracy and linearity of the microplate bicinchoninic protein assay: analytical challenges and method modifications to minimize systematic errors. Anal Biochem. 2021;631:114321. doi:10.1016/j.ab.2021.114321.
   PubMed Web of Science ®Google Scholar
• Taylor SC, Posch A. The design of a quantitative western blot experiment. Biomed Res Int. 2014;2014:361590. doi:10.1155/2014/361590.
   PubMed Web of Science ®Google Scholar
• Magaki S, Hojat SA, Wei B, So A, Yong WH. An introduction to the performance of immunohistochemistry. Methods Mol Biol. 2019;1897:289–298. doi:10.1007/978-1-4939-8935-5_25.
   PubMedGoogle Scholar